• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Cell . Structural and Functional Analysis of the D614G SARS-CoV-2 Spike Protein Variant

tetano

Editor, Senior Moderator
Cell


. 2020 Sep 15;S0092-8674(20)31229-0.
doi: 10.1016/j.cell.2020.09.032. Online ahead of print.
Structural and Functional Analysis of the D614G SARS-CoV-2 Spike Protein Variant


Leonid Yurkovetskiy[SUP] 1 [/SUP], Xue Wang[SUP] 2 [/SUP], Kristen E Pascal[SUP] 3 [/SUP], Christopher Tomkins-Tinch[SUP] 4 [/SUP], Thomas P Nyalile[SUP] 1 [/SUP], Yetao Wang[SUP] 1 [/SUP], Alina Baum[SUP] 3 [/SUP], William E Diehl[SUP] 1 [/SUP], Ann Dauphin[SUP] 1 [/SUP], Claudia Carbone[SUP] 1 [/SUP], Kristen Veinotte[SUP] 1 [/SUP], Shawn B Egri[SUP] 1 [/SUP], Stephen F Schaffner[SUP] 4 [/SUP], Jacob E Lemieux[SUP] 5 [/SUP], James B Munro[SUP] 6 [/SUP], Ashique Rafique[SUP] 3 [/SUP], Abhi Barve[SUP] 2 [/SUP], Pardis C Sabeti[SUP] 7 [/SUP], Christos A Kyratsous[SUP] 8 [/SUP], Natalya V Dudkina[SUP] 9 [/SUP], Kuang Shen[SUP] 10 [/SUP], Jeremy Luban[SUP] 11 [/SUP]



Affiliations

Abstract

The SARS-CoV-2 spike (S) protein variant D614G supplanted the ancestral virus worldwide, reaching near fixation in a matter of months. Here we show that D614G was more infectious than the ancestral form on human lung cells, colon cells, and on cells rendered permissive by ectopic expression of human ACE2 or of ACE2 orthologs from various mammals, including Chinese rufous horseshoe bat and Malayan pangolin. D614G did not alter S protein synthesis, processing, or incorporation into SARS-CoV-2 particles, but D614G affinity for ACE2 was reduced due to a faster dissociation rate. Assessment of the S protein trimer by cryo-electron microscopy showed that D614G disrupts an interprotomer contact and that the conformation is shifted toward an ACE2 binding-competent state, which is modeled to be on pathway for virion membrane fusion with target cells. Consistent with this more open conformation, neutralization potency of antibodies targeting the S protein receptor-binding domain was not attenuated.

Keywords: ACE2; COVID-19; SARS-CoV-2; Spike protein; coronavirus; cryo-electron microscopy; infectivity; neutralizing antibody; pandemic.
 
Back
Top Bottom